Corporate Inquiry

Connect with Rivus

Direct pathways for institutional investors, clinical investigators, and prospective pharmaceutical partners seeking to engage with our metabolic development platform.

Investor Relations

Clinical Sites

Business Development

Access secure corporate updates, clinical trial milestones, and institutional financial presentations.

Inquire about active Phase 2 protocols, investigator resources, and multi-center site selection.

Explore strategic licensing, co-development, and mitochondrial platform collaborations.

Secure Portal

Initiate a partnership

Submit your credentials and area of interest. Our corporate development team will review the inquiry and respond through secure channels within two business days.